Beyond Multi-System Disease
It is now reasonably well established that HS involves more than the skin — that gut function, hormonal regulation, immune signalling, and metabolic processes all participate in the disease. What is less well articulated is the precise nature of that participation. The systems involved in HS are not simply malfunctioning in parallel, each contributing its own dysfunction to a common outcome. They have lost the ability to coordinate their regulatory responses — and in doing so, they actively amplify each other's failure.
This distinction is clinically significant. A disease in which multiple systems are independently dysfunctional can, in principle, be addressed by correcting each system independently. A disease in which those systems have lost their mutual regulatory capacity cannot be corrected that way — because correcting any single system in isolation produces incomplete results, because the other systems continue to undermine the correction. Understanding HS as a coordination disorder — rather than simply a multi-system disease — changes what an adequate treatment approach must accomplish.
"When a condition keeps recurring, it usually follows an underlying pattern that needs to be understood and addressed — not suppressed."
How the Coordination Breaks Down
In a well-functioning body, the major regulatory systems communicate continuously and adjust each other's output in ways that maintain systemic balance. The immune system modulates the intensity of its inflammatory responses based on regulatory signals from the gut microbiome, the neuroendocrine system, and the metabolic environment. The endocrine system calibrates its hormonal output based on immune signals, metabolic state, and neurological input. The gut microbiome regulates its composition based on dietary inputs, immune signals, and the hormonal environment — and in turn generates signals that influence all three of those systems.
This mutual regulation is what allows the body to mount a proportionate inflammatory response and then resolve it; to produce hormones in appropriate quantities relative to metabolic demand; to maintain an intestinal environment that processes inputs effectively without generating systemic burden. When the coordination is intact, disruptions in one system are buffered by the regulatory responses of the others. A brief gut insult does not produce sustained systemic inflammation, because the immune system's regulatory capacity contains the response. A hormonal fluctuation does not produce a severe HS flare, because the immune system's threshold is calibrated to respond proportionately.
In HS, this coordination has been compromised. The gut is no longer generating the regulatory microbiome signals that would contain immune activation. The immune system, without these signals, is operating at an elevated baseline — one that is no longer buffered by the regulatory inputs that would normally moderate it. The hormonal system, without adequate immune regulation and with impaired metabolic function, is producing androgens and insulin in quantities that exceed what the system can process without inflammatory consequence. Each system's regulatory failure removes a buffer that would otherwise limit the other systems' dysregulation. The failures compound.
The Self-Amplification Loop
The most clinically consequential feature of this coordination breakdown is self-amplification. Because the systems involved in HS are mutually regulatory under normal conditions, their collective dysregulation creates feedback loops that maintain and deepen the disease state without requiring any new external input to sustain it.
Consider a specific loop: gut dysbiosis impairs the production of short-chain fatty acids that maintain intestinal barrier integrity and modulate immune activation. As the barrier weakens, more inflammatory material enters systemic circulation. The immune system responds with elevated activation — consuming regulatory capacity that would otherwise limit the hormonal axis. As immune regulation of the endocrine system decreases, adrenal androgen output increases. Elevated androgens worsen gut motility and alter the hormonal environment of the gut, selecting for microbial populations that further dysregulate the microbiome. The original gut dysbiosis is now being amplified by the hormonal change that it helped produce. The loop is self-sustaining.
This is not a theoretical construct. It is the mechanistic explanation for why long-standing HS tends to become progressively more difficult to manage — not because the disease has acquired new properties, but because the self-amplifying loops have had more time to entrench, and the overall level of coordination failure has deepened. It is also why removing a single element from the loop — treating the gut, or addressing hormones, or suppressing immune activation — produces partial and temporary results. The other elements of the loop continue operating and, in most cases, eventually re-establish the element that was corrected.
The Ayurvedic concept of Srotorodha — the obstruction of the body's regulatory channels — captures an important dimension of what happens in HS as a coordination disorder. The Srotas are not simply anatomical channels; they are the pathways through which regulatory signals, nutritive substances, and waste products move between systems. When Srotorodha develops — whether through Ama accumulation, Dosha aggravation, or structural blockage — the regulatory communication between systems is impaired. Each system begins to function in relative isolation from the moderating influence of the others. In HS, Srotorodha is particularly relevant to the Rasavaha Srotas (channels of nutritive plasma and immune signalling), the Raktavaha Srotas (blood channels), and the Medovaha Srotas (metabolic and adipose channels). The obstruction of these channels is not merely a symptom of the disease — it is a structural feature that must be addressed as part of correction, because unblocking regulatory communication between systems is what allows them to begin modulating each other's activity again.
Why Single-System Intervention Consistently Falls Short
The self-amplifying coordination failure in HS explains a clinical pattern that is familiar to many patients: the experience of a treatment that produces meaningful improvement in one dimension of the disease, while the overall condition continues to worsen or fails to consolidate.
A patient who successfully addresses hormonal imbalance through appropriate endocrine intervention may find that HS activity reduces in its hormonal component — but that the gut-mediated inflammatory baseline continues to sustain lesion activity at a level that prevents full improvement. A patient who corrects gut function through dietary and microbiome-directed intervention may find that the gut's improved regulatory output begins to reduce systemic inflammation — but that the established hormonal imbalance continues to create follicular susceptibility that produces new lesions. In each case, the intervention is addressing a real component of the disease. But the coordination failure means that the untreated components continue to amplify what is being corrected.
This is not a failure of the specific interventions. It is a consequence of applying interventions designed for single-system diseases to a condition that is fundamentally a coordination disorder. Correcting one node in a mutually amplifying network is not sufficient to interrupt the network. What is required is a structured approach that simultaneously — or sequentially in a way that accounts for the dependencies — reduces the amplification loops by correcting the systems that are feeding each other's dysfunction.
What Correcting a Coordination Disorder Requires
Correcting a coordination disorder requires a different treatment logic from correcting a single-system disease. The goal is not simply to reduce dysfunction in each involved system. It is to restore sufficient regulatory communication between systems that they begin to buffer each other's activation — as they do in a healthy body — rather than amplify it.
This requires sequencing that respects the dependencies between systems. Gut restoration is foundational because it re-establishes the regulatory microbiome signals on which immune and hormonal regulation depend. Without this foundation, interventions at the immune and hormonal level are working against a gut environment that continues to undermine them. Inflammation reduction is the second requirement — because until the systemic inflammatory baseline is reduced, tissue healing cannot occur in an environment that is actively destroying what is being rebuilt. Hormonal correction, in the context of a more regulated gut and a reduced systemic inflammatory load, can then be effective in a way that it cannot be when those preceding conditions have not been met.
Recognising Recovery of Coordination
One of the distinctive features of genuine correction in HS — as opposed to symptom suppression — is the eventual recovery of inter-system regulatory capacity. When the coordination is beginning to be restored, the systems involved start to buffer each other's activation rather than amplifying it. This manifests clinically as a reduction in the volatility of the disease: flares that were previously explosive and rapid become slower to develop and more tractable to resolution. Hormonal fluctuations that previously produced severe lesion activity produce milder responses. Gut disruptions that would previously have triggered significant HS activity produce only minor effects.
This increasing resilience to triggers is one of the most reliable indicators that the correction is reaching beyond symptom control to the level of actual coordination recovery. The disease is not simply quieter. It is less reactive — because the amplification loops that were producing its reactivity are being interrupted at their structural level, not merely suppressed at their expression.
"The goal is not just to control symptoms, but to understand why the condition is occurring in the first place."
The Practical Implication
Understanding HS as a coordination disorder has a clear practical implication: the evaluation of what is driving a patient's HS must be comprehensive enough to identify which specific coordination failures are most prominent, and the treatment must be structured in a way that addresses the dependencies between those failures rather than treating each in isolation.
This requires more from the initial evaluation than a skin-focused assessment provides. It requires understanding the gut's current functional state, the hormonal profile and its metabolic context, the immune system's current activation level and its regulatory capacity, and how long the coordination failure has been established — since the duration directly affects how deeply the amplification loops have entrenched and therefore how structured and sustained the correction needs to be.
None of this complexity is a reason for discouragement. Coordination disorders are correctable — precisely because the systems involved are designed to regulate each other, and given the right conditions, they can begin to do so again. The requirement is not a more aggressive intervention. It is a more intelligent one: one that understands the architecture of the failure and addresses it in a sequence that respects how the systems involved actually depend on each other.